Computers in Pharmaceutical Formulation

Computer Applications in Pharmaceutical Research and Development

Volumn , Issue , 2006, Pages 677-701

  Rowe, Raymond C ^a   Colbourn, Elizabeth A ^b  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b Intelligensys Ltd   (United Kingdom)

Author keywords

Computer simulation; Computers in pharmaceutical formulation; Neural computing

Indexed keywords

EID: 84889869835     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470037237.ch28     Document Type: Chapter

References (76)

1. Sell PS. Expert systems-a practical introduction. Basingstoke, UK: Camelot Press, 1985.
2. Partridge D, Hussain KM. Knowledge-based information systems. London: McGraw, 1994.
3. Bradshaw D. The computer learns from experts. Financial Times London 27 April 1989.
4. Walko JZ. Turning Dalton's theory into practice. Innovation 1989;18:24.
5. Turner J. Product formulation expert system. Manufacturing Intelligence 1991;14:13-15.
6. Bentley P. Product Formulation Expert System (PFES). In: Rowe RC, Roberts RJ, Intelligent software for product formulation. London: Taylor and Francis, 1998. pp. 27-41.
7. Goodall A. Preface. In: Althoff KD, A review of industrial case-based reasoning tools. Oxford: AI Intelligence, 1995.
8. Aamodt A, Plaza E. Case-based reasoning-foundational issues, methodological variations and system approaches. AI Commun 1994;7:39-59.
9. Watson I. Applying case-based reasoning: techniques for enterprising systems. San Francisco: Morgan Kaufmann, 1997.
10. Stricker H, Haux R, Wetter T, Mann G, Oberhammer L, Flister J, Fuchs S, SchmelmerV. Das Galenische Entwicklungs-System Heidelberg. Pharm Ind 1991;53:571-8.
11. Stricker H, Fuchs S, Haux R Rossler R, Rupprecht B, Schmelmer V, Wiegel S. Das Galenische Entwicklungs-System Heidelberg-Systematische Rezepturentwicklung. Pharm Ind 1994;56:641-7.
12. Frank J, Rupprecht B, Schmelmer V. Knowledge-based assistance for the development of drugs. IEEE Expert 1997;12:40-8.
13. Ramani KV, Patel MR, Patel SK. An expert system for drug preformulation in a pharmaceutical company. Interfaces 1992;22:101-8.
14. Rowe RC. Expert systems in solid dosage development. Pharm Ind 1993;55:1040-5.
15. Rowe RC, Roberts RJ. Intelligent software for product formulation. London: Taylor and Francis, 1998.
16. Rowe RC, Roberts RJ. Expert systems in pharmaceutical development. In Swarbrick J, Boylan JC, editors, Encyclopedia of pharmaceutical technology 2nd edition. New York: Marcel Dekker, 2002. pp. 1188-1210.
17. Rowe RC, Craw S, Wiratunga N. Case-based reasoning-a new approach to tablet formulation. Pharm Tech Eur 1999;11(2):36-40.
18. Kashihara T, Takahashi Y. Development of computer aided formulation system for tablet (Expert-Tab) 1. Pharm Tech Japan 2001;17:699-711.
19. Kashihara T, Development of computer aided formulation system for tablet (expert-Tab) 2. Pharm Tech Japan 2001;17:839-56.
20. Kusai A. Development of computer aided formulation system for tablet (expert-Tab) 3. Pharm Tech Japan 2001;17:1007-13.
21. Bentham C. Expert system in formulation design, In Proceedings Computer Aided Formulation, Coventry, UK 17th October 2001. Reading: Faraday Impact Partnership.
22. Lai S, Podczeck F, Newton JM, Daumesnil R. An expert system to aid the development of capsule formulations. Pharm Tech Eur 1996;12(9):60-8.
23. Kashihara T, Yoshioka M. Assessment in Japanese Focus Group. In Hashida M, editor, Formulation design of oral dosage forms. Yakagyo-Jiho, 1998. pp. 244-53.
24. Bateman SD, Verlin J, Russo M, Guillot M, Laughlin SM. The development and validation of a capsule formulation knowledge based system. Pharm Tech 1996;20(3):174-84.
25. Rowe RC, Wakerly MG, Roberts RJ, Grundy RU, Upjohn NG. Expert Systems for Parenteralo Development. J Pharm Sci Technol 1995;49:257-61.
26. Rowe RC, Hall J, Roberts RJ. Film coating formulation using an expert system Pharm Tech Eur 1998;10(10):72-82.
27. Wood M. Expert systems save formulation time. Lab Equipment Digest 1991 (December) 17-19.
28. Byrd TA. Expert systems in production and operations management; results of a survey. Interfaces 1993;23:118-29.
29. Achanta AS, Kowalsk JG, Rhodes CT. Artificial neural networks: implications for pharmaceutical sciences. Drug Dev Ind Pharm 1995;21:119-55.
30. Bourquin J, Schmidli H, van Hoogevest P, Leuenberger H. Basic concepts of artificial neural networks (ANN) modelling in the application to pharmaceutical development. Pharm Dev Technol 1997;2:95-109.
31. Takayama K, Fujikawa M, Nagai T. Artificial neural networks as a novel method to optimize pharmaceutical formulations. Pharm Res 1999;16:1-6.
32. Rowe RC, Colbourn EA. Applications of neural computing in formulation. Pharmaceutical Visions 2002. Spring Edition, 4-7.
33. Turkoglu J, Ozarslan R, Sakr A. Artificial neural network analysis of a direct compression tabletting study. Eur J Pharm Biopharm 1995;41:315-22.
34. Kesavan JG, Peck GE. Pharmaceutical granulation and tablet formulation using neural networks. Pharm Dev Technol 1996;1:391-404.
35. Colbourn EA, Rowe RC. Modelling and optimization of a tablet formulation using neural networks and genetic algorithms. Pharm Tech Eur 1996;8(9): 46-55.
36. Rowe RC, Colbourn EA. Generating rules for tablet formulations. Pharm Tech Eur 2000;12(1):24-7.
37. Bourquin J, Schmidli H, van Hoogevest P, Leuenberger H. Application of artifi-cial neural networks (ANN) in the development of solid dosage forms. Pharm Dev Technol 1997;2:111-21.
38. Bourquin J, Schmidli H, van Hoogevest P, Leuenberger H. Comparison of artifi-cial neural networks (ANN) with classical modelling technologies using different experimental designs and data from a galenical study on a solid dosage form. Eur J Pharm Sci 1998;6:287-300.
39. Bourquin J, Schmidli H, van Hoogevest P, Leuenberger H. Advantages of artifi-cial neural networks (ANNs) as alternative modelling technique for data sets showing non-linear relationships using data from a galenical study on a solid dosage form. Eur J Pharm Sci 1998;7:5-16.
40. Bourquin J, Schmidli H, van Hoogevest P, Leuenberger H. Pitfalls of artificial neural networks (ANN) modelling technique for data sets containing outlier measurements using a study of mixture properties of a direct compressed tablet dosage form. Eur J Pharm Sci 1998;7:17-28.
41. Do Q M., Dang GV, Le NQ. Drawing up and optimizing the formulation of Malumix tablets by an artificial intelligence system (CAD/Chem). Tap Chi Duoc Hoc 2000;6:16-19.
42. Rocksloh K, Rapp F-R, Abu Abed S, Mueller W, Reher M, Gauglitz G, Schmidt PC. Optimization of crushing strength and disintegration time of a high dose plant extract tablet by neural networks. Drug Dev Ind Pharm 1999; 25:1015-25.
43. Chen U, Thosor SS, Forbess RA, Kemper MS, Rubinovitz RL, Shukla AJ. Prediction of drug content and hardness of intact tablets using artificial neural networks and near-infrared spectroscopy. Drug Dev Ind Pharm 2001;27:623-31.
44. Sathe PM, Venitz J. Comparison of neural networks and multiple linear regression as dissolution predictors. Drug Dev Ind Pharm 2003;29:349-55.
45. Lindberg N-O, Colbourn EA. Use of artificial neural networks and genetic algorithms-experiences from a tablet formulation. Pharm Tech Eur 2004;16(5): 35-9.
46. Plumb AP, Rowe RC, York P, Doherty C. The effect of experimental design in the modelling of a tablet coating formulation using artificial neural networks. Eur J Pharm Sci 2002;16:281-8.
47. Plumb AP, Rowe RC, York P, Doherty C. Effect of varying optimization parameters in optimization by guided evolutionary simulated annealing (GESA) usinga tablet film coat on an example formulation. Eur J Pharm Sci 2003;18:259-66.
48. Rowe RC, Woolgar CG. Neurofuzzy logic in tablet film coating formulation. Pharmaceut Sci Technol Today 1999;2:495-7.
49. Hussain AS, Yu X, Johnson RD. Application of neural computing in pharmaceutical product development. Pharm Res 1991;8:1248-52.
50. Hussain AS, Shivanand P, Johnson RD. Application of neural computing in pharmaceutical product development: computer aided formulation design. Drug Dev Ind Pharm 1996;20:1739-52.
51. Takahara J, Takayama K, Nagai T. Multi-objective simultaneous optimization technique based on an artificial neural network in sustained release formulations. J Controlled Release 1997;49:11-20.
52. Zupancic Bozic D, Vrecar F, Kozjek F. Optimization of diclofenac sodium dissolution from sustained release formulations using an artificial neural network. Eur J Pharm Sci 1997;5:163-9.
53. Sheng H, Wang P, Tu J.-S, Yuan L, Pin Q-N. Applications of artificial neural networks to the design of sustained release matrix tablets. Chinese J Pharmaceut 1998;29:352-4.
54. Ibric S, Jovanovic M, Djuric A, Parojcic J, Petrovic SD, Solomun L, Stupor B. Artificial neural networks in the modelling and optimization of aspirin extended release tablets with Eudragit L100 as matrix substance. Pharm Sci Tech 2003;4:62-70.
55. Wu T, Pao W, Chen J, Shang R. Formulation optimization technique based on artificial neural network in salbutamol sulfate osmotic pump tablets. Drug Dev Ind Pharm 2000;26:211-15.
56. Leane MM, Cumming I, Corrigan O. The use of artificial neural networks for the selection of the most appropriate formulation and processing variables in order to predict the in vitro dissolution of sustained release minitablets. Pharm Sci Tech 2003;4:218-29.
57. Takahara J, Takayama K, Isowa K, Nagai T. Multi-objective simultaneous optimization based on artificial neural network in a ketoprofen hydrogel formula containing σ-ethylmenthol as a percutaneous absorption enhancer. Int J Pharm 1997;158:203-10.
58. Takayama K, Takahara J, Fujikawa M, Ichikawa H, Nagai T. Formula optimization based on artificial neural networks in transdermal drug delivery. J Controlled Release 1999;62:161-70.
59. Wu P-C, Obata Y, Fijukawa M, Li CJ, Higashiyama K, Takayama K. Simultaneous optimization based on artificial neural networks in ketoprofen hydrogel formula containing σ-ethyl-3-burylcyclohexanol as a percutaneous absorption enhancer. J Pharm Sci 2001;90:1004-14.
60. Agatonovic-Kustrin S, Alany RG. Role of genetic algorithms and artificial neural networks in predicting phase behaviour of colloidal delivery systems. Pharm Res 2001;18:1049-55.
61. Agatonovic-Kustrin S, Glass BD, Wisch MH, Alany RG. Prediction of a stable microemulsion formulation for the oral delivery of a combination of antitubercular drugs using ANN technology. Pharm Res 2003;20:1760-5.
62. Kandimalla KK, Kanikkannon N, Singh M. Optimization of a vehicle mixture for the transdermal delivery of melatonin using artificial neural networks and response surface method. J Controlled Release 1999;61:71-82.
63. Peh KK, Lim CP, Qwek SS, Khoti KH. Use of artificial networks to predict drug dissolution profiles and evaluation of network performance using similarity profile. Pharm Res 2000;17:1386-98.
64. Turkoglu M, Varol H, Celikok M. Tableting and stability evaluation of entericcoated omeprazole pellets. Eur J Pharm Biopharm 2004;57:277-86.
65. Yuksel N, Turkoglu M, Baykara T. Modelling of the solvent evaporation method for the preparation of controlled release acrylic microspheres using neural networks. J Microencapsulation 2000;17:541-51.
66. Surini S, Akiyama H, Morishita M, Nagai T, Takayama K. Release phenomena of insulin from an implantable device composed of a polyion complex of chitosan and sodium hyaluronate. J Controlled Release 2003;90:291-301.
67. Reis MAA, Sinisterra RO, Belchior JC. An alternative approach based on artificial neural networks to study controlled drug release. J Pharm Sci 2004; 93:418-28.
68. Rees C. Neural Computing-Learning Solutions-User Survey. Department of Trade and Industry, London, UK, 1996.
69. Al-Khattat IM, Al-Hassani STS. Towards a computer-aided analysis and design of tablet compaction. Chem Eng Sci 1987;44:707-12.
70. Michrafy A, Ringenbacher D, Tchoreloff P. Modelling the compaction behaviour of powders: Application to pharmaceutical powders. Powder Technol. 2002;127:257-66.
71. Wu C-Y, Ruddy OM, Bentham AC, Hancock BC, Best SM, Elliot JA. Modelling the mechanical behaviour of pharmaceutical powders during compaction. Powder Technol 2005;152:107-17.
72. Lewis RW, Gethin DT, Yang XS, Rowe RC. A combined finite-discrete element method for simulating pharmaceutical powder tableting. Int J Num Meth Eng 2005;62:853-69.
73. Yang XS, Lewis RW, Gethin DT, Rowe RC. Modelling of pharmaceutical powder compaction and tableting: effect of particle sizes and irregular shape. Powder Technol. 2005 in press.
74. Rowe RC, York P, Colbourn EA, Roskilly S. The influence of pellet shape, size and distribution on capsule filling-a preliminary evaluation of three dimensional computer simulation using a Monte Carlo technique. Int J Pharm 2005; 300:32-7.
75. Rowe RC, Roberts RJ. Simulation of crack propagation in tablet film coatings containing pigments. Int J Pharm 1992;78:49-57.
76. Rowe RC, Roberts RJ. The effect of some formulation variables on crack propagation in pigmented tablet film coatings using computer simulation. Int J Pharm 1992;86:49-58.